7α-18F-fluoromethyl-dihydrotestosterone and 7α- 18F-fluoromethyl-nortestosterone: Ligands to determine the role of sex hormone-binding globulin for steroidal radiopharmaceuticals

Journal of Nuclear Medicine

Volumn 49, Issue 6, 2008, Pages 987-994

  Parent, Ephraim E ^a   Dence, Carmen S ^b   Sharp, Terry L ^b   Welch, Michael J ^b   Katzenellenbogen, John A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

18F; Androgen receptor; PET; Prostate cancer; Sex hormone binding globulin

Indexed keywords

7 ALPHA FLUOROMETHYL DIHYDROTESTOSTERONE F 18; 7 ALPHA FLUOROMETHYL NORTESTOSTERONE F 18; ANDROGEN RECEPTOR; DIETHYLSTILBESTROL; RADIOPHARMACEUTICAL AGENT; SEX HORMONE BINDING GLOBULIN; DIAGNOSTIC AGENT; LIGAND;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; DEFLUORINATION; LIGAND BINDING; MALE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROSTATE; RADIOCHEMISTRY; RAT; SYNTHESIS; ANIMAL; ANTIBODY SPECIFICITY; EVALUATION; METABOLIC CLEARANCE RATE; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANIMALS; LIGANDS; MALE; METABOLIC CLEARANCE RATE; ORGAN SPECIFICITY; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; SEX HORMONE-BINDING GLOBULIN; TISSUE DISTRIBUTION;

EID: 44849119495     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.048926     Document Type: Article

References (38)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003;53:5-26.
2. de Ronde W, van der Schouw YT, Muller M, et al. Associations of sex-hormone-binding globulin (SHBG) with non-SHBG-bound levels of testosterone and estradiol in independently living men. JClin Endocrinol Metab. 2005;90:157-162.
3. Vermeulen A. Reflections concerning biochemical parameters of androgenicity. Aging Male. 2004;7:280-289.
4. Adams JS. "Bound" to work: the free hormone hypothesis revisited. Cell. 2005;122:647-649.
5. Hammes A, Andreassen TK, Spoelgen R, et al. Role of endocytosis in cellular uptake of sex steroids. Cell. 2005;122:751-762.
6. Porto CS, Lazari MF, Abreu LC, Bardin CW, Gunsalus GL. Receptors for androgen-binding proteins: internalization and intracellular signalling. J Steroid Biochem Mol Biol. 1995;53:561-565.
7. Rosner W. Sex steroids and the free hormone hypothesis. Cell. 2006;124:455-456.
8. Willnow TE, Nykjaer A. Response: cellular uptake of sex steroid hormones. Cell. 2006;124:456-457.
9. 18F]fluoro-19-nor-5α-dihydrotestosterone: preparation via halofluorination-reduction, receptor binding, and tissue distribution. J Med Chem. 1995;38:816-825.
10. 18F]fluoromibolerone, a positron-emitting radiotracer for androgen receptors: synthesis and tissue distribution studies. J Nucl Med. 1991;32:81-88.
11. Liu A, Carlson KE, Katzenellenbogen JA. Synthesis of high-affinity fluorine-substituted ligands for the androgen receptor: potential agents for imaging prostatic cancer by positron emission tomography. J Med Chem. 1992;35:2113-2129.
12. Hobbs CJ, Jones RT, Plymate SR. The effects of sex hormone binding globulin (SHBG) on testosterone transport into the cerebrospinal fluid. J Steroid Biochem Mol Biol. 1992;42:629-635.
13. Reventos J, Sullivan PM, Joseph DR, Gordon JW. Tissue-specific expression of the rat androgen-binding protein/sex hormone-binding globulin gene in transgenic mice. Mol Cell Endocrinol. 1993;96:69-73.
14. Bonasera TA, O'Neil JP, Xu M, et al. Preclinical evaluation of fluorine-18-labeled androgen receptor ligands in baboons. J Nucl Med. 1996;37:1009-1015.
15. Muntzing J, Myhrberg H, Saroff J, Sandberg AA, Murphy GP. Histochemical and ultrastructural study of prostatic tissue from baboons treated with antiprostatic drugs. Invest Urol. 1976;14:162-167.
16. Kaack B, Lewis RW, Resnick MI, Roberts JA. Biochemistry of the nonhuman primate prostate and seminal vesicles. I. Some chemical parameters. Arch Androl. 1983;11:123-129.
17. Liu A, Dence CS, Welch MJ, Katzenellenbogen JA. Fluorine-18-labeled androgens: radiochemical synthesis and tissue distribution studies on six fluorine-substituted androgens, potential imaging agents for prostatic cancer. J Nucl Med. 1992;33:724-734.
18. 18F-FDG in patients with progressive, metastatic prostate cancer. J Nucl Med. 2004;45:366-373.
19. Dehdashti F, Picus J, Michalski JM, et al. Positron tomographic assessment of androgen receptors in prostatic carcinoma. Eur J Nucl Med Mol Imaging. 2005;32:344-350.
20. Downer JB, Jones LA, Engelbach JA, et al. Comparison of animal models for the evaluation of radiolabeled androgens. Nucl Med Biol. 2001;28:613-626.
21. Jonson SD, Wang J, Jury HH, Tsvetnitsky V, Hammong GL, Welch MJ. Role of sex hormone-binding globulin in target uptake of radiolabelled steroids: investigations in transgenic models. J Labelled Comp Radiopharm. 1999;42(suppl):S16-S18.
22. Dehdashti F, Mortimer JE, Siegel BA, et al. Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. J Nucl Med. 1995;36:1766-1774.
23. 18F] fluoro-17β-estradiol uptake in metastatic breast carcinoma. J Nucl Med. 1991;32:1526-1531.
24. Mintun MA, Welch MJ, Siegel BA, et al. Breast cancer: PET imaging of estrogen receptors. Radiology. 1988;169:45-48.
25. Kiesewetter DO, Kilbourn MR, Landvatter SW, Heiman DF, Katzenellenbogen JA, Welch MJ. Preparation of four fluorine-18-labeled estrogens and their selective uptakes in target tissues of immature rats. J Nucl Med. 1984;25:1212-1221.
26. 18F]fluoromoxestrol in isolated hepatocytes. Nucl Med Biol. 1999;26:123-130.
27. Winqvist R, Peltoketo H, Isomaa V, Grzeschik KH, Mannermaa A, Vihko R. The gene for 17beta-hydroxysteroid dehydrogenase maps to human chromosome 17, bands q12-q21, and shows an RFLP with ScaI. Hum Genet. 1990;85:473-476.
28. Parent EE, Carlson KE, Katzenellenbogen JA. Synthesis of 7α-(fluoromethyl)-dihydrotestosterone and 7α-(fluoromethyl) nortestosterone, structurally paired androgens designed to probe the role of sex hormone binding globulin in imaging androgen receptors in prostate tumors by positron emission tomography. J Org Chem. 2007;72:5546-5554.
29. Kumar N, Sundaram K, Bardin CW. Feedback regulation of gonadotropins by androgens in rats: is 5a-reduction involved? J Steroid Biochem Mol Biol. 1995;52:105-112.
30. LaMorte A, Kumar N, Bardin CW, Sundaram K. Aromatization of 7α-methyl-19-nortestosterone by human placental microsomes in vitro. J Steroid Biochem Mol Biol. 1994;48:297-304.
31. Brandes SJ, Katzenellenbogen JA. Fluorinated androgens and progestins: molecular probes for androgen and progesterone receptors with potential use in positron emission tomography. Mol Pharmacol. 1987;32:391-403.
32. Sharp TL, Dence CS, Engelbach JA, Herrero P, Gropler RJ, Welch MJ. Techniques necessary for multiple tracer quantitative small-animal imaging studies. Nucl Med Biol. 2005;32:875-884.
33. 18F]fluoro-17α-methyl-5α-dihydrotestosterone: a ligand for androgen receptor-mediated imaging of prostate cancer. Nucl Med Biol. 2001;28:85-90.
34. 18F]fluoro) estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors. J Med Chem. 1993;36:1619-1629.
35. Zanzonico PB, Finn R, Pentlow KS, et al. PET-based radiation dosimetry in man of 18-F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancer. J Nucl Med. 2004;45:1966-1971.
36. Dehdashti F, Flanagan FL, Mortimer JE, Katzenellenbogen JA, Welch MJ, Siegel BA. Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy. Eur J Nucl Med. 1999;26:51-56.
37. Labaree DC, Hoyte RM, Nazareth LV, Weigel NL, Hochberg RB. 7a-iodo and 7a-fluoro steroids as androgen receptor-mediated imaging agents. J Med Chem. 1999;42:2021-2034.
38. Kim DW, Choe YS, Chi DY. A new nucleophilic fluorine-18 labeling method for aliphatic mesylates: reaction in ionic liquids shows tolerance for water. Nucl Med Biol. 2003;30:345-350.